SCHEMBL214549

SCHEMBL214549

NC(=O)c1[nH]cnc1C(=O)NCc1ccccc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.55
▸ GAA P10253 3/20 0.55
▸ CASP6 P55212 1/20 0.55
▸ POLB P06746 1/20 0.52
▸ CYP1A2 P05177 2/20 0.49
▸ CYP3A4 P08684 2/20 0.49
▸ CYP2C19 P33261 2/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ KMT2A Q03164 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ TP53 P04637 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ SCN2A Q99250 1/20 0.45
▸ SCN10A Q9Y5Y9 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2735282 0.78 ALDH1A1 (0.59) ALDH1A1GAACASP6NPC1RAB9A
SCHEMBL17142801 0.74 GRM4 (0.55) ALDH1A1GAANPC1RAB9ASMN1; SMN2
SCHEMBL14938844 0.72 POLB (0.54) ALDH1A1GAAPOLBCYP1A2CYP3A4
SCHEMBL625881 0.71 NPC1 (0.72) ALDH1A1POLBNPC1RAB9ASMN1; SMN2
SCHEMBL14284361 0.71 KMT2A (0.58) ALDH1A1POLBCYP1A2CYP3A4CYP2C19
SCHEMBL17703429 0.70 ALDH1A1 (0.86) ALDH1A1GAAPOLBKMT2AMAPK1
SCHEMBL950894 0.69 NPC1 (0.68) ALDH1A1GAANPC1RAB9ASMN1; SMN2
SCHEMBL2912570 0.69 SMN1; SMN2 (0.82) ALDH1A1POLBNPC1RAB9ASMN1; SMN2
SCHEMBL17143115 0.69 SMN1; SMN2 (0.54) ALDH1A1GAASMN1; SMN2KMT2ALMNA
SCHEMBL213391 0.69 ALDH1A1 (0.76) ALDH1A1GAANPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088767-B2 JAK-2 modulators and methods of use EXELIXIS, INC. (US) 2012-01-03 — — US claimed
EP-0248414-A2 Aralkyl imidazole derivatives CIBA-GEIGY AG (CH) 1987-12-09 — — EP disclosed
Send feedback